MDPI and ACS Style
Siregar, A.S.; Nyiramana, M.M.; Kim, E.-J.; Cho, S.B.; Woo, M.S.; Lee, D.K.; Hong, S.-G.; Han, J.; Kang, S.S.; Kim, D.R.;
et al. Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals. Mar. Drugs 2021, 19, 614.
https://doi.org/10.3390/md19110614
AMA Style
Siregar AS, Nyiramana MM, Kim E-J, Cho SB, Woo MS, Lee DK, Hong S-G, Han J, Kang SS, Kim DR,
et al. Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals. Marine Drugs. 2021; 19(11):614.
https://doi.org/10.3390/md19110614
Chicago/Turabian Style
Siregar, Adrian S., Marie Merci Nyiramana, Eun-Jin Kim, Soo Buem Cho, Min Seok Woo, Dong Kun Lee, Seong-Geun Hong, Jaehee Han, Sang Soo Kang, Deok Ryong Kim,
and et al. 2021. "Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals" Marine Drugs 19, no. 11: 614.
https://doi.org/10.3390/md19110614